Adenosine receptors as therapeutic targets
Open accessThe DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Abstract
Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world. There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. After more than three decades of medicinal chemistry research, a considerable number of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clinically evaluated, although none has yet received regulatory approval. However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these, A1 and A2A receptors are considered the principal targets mediating caffeine’s physiological effects.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“A key mechanism underlying the interaction between caffeine and exercise is caffeine’s pharmacological action as a competitive adenosine receptor antagonist.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Instead, competitive blockade of A1 and A2A adenosine receptors is widely regarded as the central mechanism underlying caffeine’s physiological effects during both habitual intake and exercise (Figure 1) [28,29,30,31].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“Within the range of plasma concentrations relevant to sports nutrition practice, typically micromolar levels achieved after low-to-moderate caffeine intake, caffeine’s primary mechanism of action is unlikely to involve phosphodiesterase (PDE) inhibition or direct intracellular Ca2+ release.”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [29]
In the citing paper
“This effect modulates key physiological processes such as anti-inflammatory responses, angiogenesis, and vasodilation, as illustrated in Figure 2 (left panel) [52,66,67,68].”
From Comparison of Polynucleotide and Polydeoxyribonucleotide in Dermatology: Molecular Mechanisms and Clinical Perspectives (2025) · cites this paper as [68]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Self-citationCalker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Ohta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness
Porkka-Heiskanen, T., Strecker, R. E., Thakkar, M., Bjørkum, A. A., Greene, R. W., & McCarley, R. W. (1997) · Science · doi:10.1126/science.276.5316.1265 · Cited by 1,252
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Extracellular metabolism of ATP and other nucleotides
Zimmermann, H. (2000) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s002100000309 · Cited by 990
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Adenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Research works printed but not linked: 1
- Ji, X. D. & Jacobson, K. A. [3H]-ZM241385 as a radioligand at recombinant human A2B adenosine receptors. Drug Des. Discov. 16, 217–226 (1999).
Cited by
Items 501–600 of 1,001
Kim, Y., Hechler, B., Gao, Z., Gachet, C., & Jacobson, K. A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9001689 · Cited by 34
“Each of the four subtypes of ARs (A1, A2A, A2B, and A3) is associated with characteristic pathways of signaling, typically in a speciesdependent manner (12).”
BackgroundMethodSelf-citationUnlocking the Potential of Purinergic Signaling in Transplantation
Zeiser, R., Robson, S. C., Vaikunthanathan, T., Dworak, M., & Burnstock, G. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13801 · Cited by 36
“Signaling cascades of adenosine receptors, however, are much more complex because they have also been shown to modulate protein kinase C, phosphoinositide 3 kinase and mitogen-activated protein kinases (reviewed by Jacobson and Gao [99]).”
BackgroundAnti-inflammatory Effect of DNA Polymeric Molecules in a Cell Model of Osteoarthritis
Baek, A., Kim, M., Kim, S. H., Cho, S.-R., & Kim, H. J. (2018) · Inflammation · doi:10.1007/s10753-017-0722-2 · Cited by 33
“Adenosine is a purine nucleoside released in response to several types of stress conditions [13] and also interacts with its own four receptors, including A1, A2A, A2B, and A3, to regulate inflammation [29].”
BackgroundJakovljevic, M., Lavrnja, I. C., Bozic, I. D., Milosevic, A., Bjelobaba, I. M., Savić, D. Z., Sévigny, J., Peković, S., Nedeljković, N., & Laketa, D. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00410 · Cited by 38
“Finally, e-5NT/CD73, abundantly expressed by astrocytes, vascular endothelium, and choroid plexus epithelium (Jacobson and Gao, 2006; Mills et al., 2008; Lavrnja et al., 2015), generates adenosine (Zimmermann, 1992) which activates G-protein coupled adenosine receptor subtypes, A1, A2A, A2B, and A3 (Fredholm et al.”
BackgroundExtracellular adenosine 5′-triphosphate in pulmonary disorders
Pelleg, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114319 · Cited by 36
Purinergic Signalling in the Cochlea
Vlajkovic, S. M., & Thorne, P. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314874 · Cited by 33
“Adenosine is a naturally occurring purine nucleoside that mediates its physiological actions by interacting with four cell surface-located adenosine receptors (A1, A2A, A2B, A3) distributed throughout the body [74].”
BackgroundSpecies dependence of A3 adenosine receptor pharmacology and function
Gao, Z., Auchampach, J. A., & Jacobson, K. A. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09910-1 · Cited by 33
Self-citationVolpini, R., Ben, D. D., Lambertucci, C., Marucci, G., Mishra, R. C., Ramadori, A. T., Klotz, K., Trincavelli, M. L., Martini, C., & Cristalli, G. (2009) · ChemMedChem · doi:10.1002/cmdc.200800434 · Cited by 33
Rajagopal, M., & Pao, A. C. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.143404 · Cited by 33
Schwartzman, J. D., McCall, M., Ghattas, Y. S., Pugazhendhi, A. S., Wei, F., Ngo, C., Ruiz, J., Seal, S., & Coathup, M. J. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122683 · Cited by 36
Ciruela, F., Fernández‐Dueñas, V., Llorente, J., Borroto‐Escuela, D. O., Cuffí, M. L., Carbonell, L., Sánchez, S., Agnati, L. F., Fuxé, K., & Tasca, C. I. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.056 · Cited by 35
Inamdar, G. S., Pandya, A. N., Thakar, H. M., Sudarsanam, V., Kachler, S., Sabbadin, D., Moro, S., Klotz, K., & Vasu, K. K. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.020 · Cited by 32
Spooner, R., DeGuzman, J., Lee, K., & Yilmaz, Ö. (2014) · Molecular Oral Microbiology · doi:10.1111/omi.12045 · Cited by 32
“Porphyromonas gingivalis infection elevates intracellular cAMP levels via A2a receptor Adenosine receptors, including A2a, are G-protein coupled receptors that act through adenylyl cyclase to alter the concentration of intracellular cAMP (Jacobson & Gao, 2006).”
Carbajales, C., Azuaje, J., de Oliveira, A. L. N., Loza, M. I., Brea, J. M., Cadavid, M. I., Masaguer, C. F., Xerardo Garcia-mera, B., Gutiérrez‐de‐Terán, H., & Sotelo, E. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00138 · Cited by 32
Microwave-assisted chemistry of purines and xanthines. An overview
Manvar, A. T., & Shah, A. K. (2013) · Tetrahedron · doi:10.1016/j.tet.2013.06.034 · Cited by 32
SPECT assessment of brain activation induced by caffeine: no effect on areas involved in dependence
Nehlig, A., Armspach, J., & Namer, I. J. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.2/anehlig · Cited by 33
The full activation mechanism of the adenosine A 1 receptor revealed by GaMD and Su-GaMD simulations
Li, Y., Sun, J., Li, D., & Lin, J. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2203702119 · Cited by 31
D’Alimonte, I., Flati, V., D’Auro, M., Toniato, E., Martinotti, S., Rathbone, M. P., Jiang, S., Ballerini, P., Iorio, P. D., Caciagli, F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.720 · Cited by 39
“These antagonists, widely used to show selective effects caused by adenine-based purines on specific receptor sites (55, 56), have been used also by our group to demonstrate the involvement or not of these compounds in the effects promoted by guanosine (37, 43).”
RetractedVelot, É., Haas, B., Léonard, F., Ernens, I., Rolland-Turner, M., Schwartz, C., Longrois, D., Devaux, Y., & Wagner, D. R. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn201 · Cited by 36
Adenosine A 2A Receptor Contributes to Ischemic Brain Damage in Newborn Piglet
Yang, Z.-J., Wang, B., Kwansa, H. E., Heitmiller, K., Hong, G., Carter, E. L., Jamrogowicz, J. L., Larson, A. C., Martin, L. J., & Koehler, R. C. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.117 · Cited by 32
Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures
Li, M., Kang, R., Shi, J., Liu, G.-T., & Zhang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067060 · Cited by 36
“More importantly, systemic application of the adenosine A1 receptor agonist 2-chloro-N 6-cyclopentyladenosine (CCPA) suppressed epileptic discharges in a mouse model of drug-resistant epilepsy [38].”
BackgroundInfluentialSun, W., Moore, J. N., Hurley, D. J., Vandenplas, M. L., Linden, J. M., Cao, Z., & Murray, T. F. (2007) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.08.011 · Cited by 35
Kovács, Z., Dobolyi, Á., Kékesi, K. A., & Juhász, G. D. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320340003 · Cited by 32
“Thus, increased activity of e5’NT after brain injury, epilepsy and other conditions may be an adaptive response that increases the levels of extracellular Ado and enhances its neuroprotective/anti-epileptic/anti-epileptogenetic effects via A1 receptors [1, 13, 79, 349].”
BackgroundInfluentialHow we manage haemostasis during sepsis
Scully, M., & Levi, M. M. (2019) · British Journal of Haematology · doi:10.1111/bjh.15821 · Cited by 32
“Adenosine not only has an inhibitory effect on platelet responses but also has wide-ranging effects on other pathways involved in innate immunity and may have a protective effect against pulmonary injury (Jacobson & Gao, 2006).”
BackgroundThe metabolic characteristic of decidual immune cells and their unique properties in pregnancy loss*
Zhang, T., Shen, H., Qin, X., & Li, M. (2022) · Immunological Reviews · doi:10.1111/imr.13085 · Cited by 35
Preteroti, M., Wilson, E. T., Eidelman, D. H., & Baglole, C. J. (2023) · Respiratory Research · doi:10.1186/s12931-023-02399-1 · Cited by 42
“Their activation leads to inhibition of T cell differentiation, downregulation of neutrophil superoxide production, as well as an inhibition of pro-inflammatory cytokine production [76].”
BackgroundGlial cell changes in epilepsy: Overview of the clinical problem and therapeutic opportunities
Hubbard, J. A., Hsu, M. S., Fiacco, T. A., & Binder, D. K. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.017 · Cited by 34
“The therapeutic benefits of adenosine, adenosine receptor agonists, and ADK inhibitors has been widely recognized as effective seizure suppressors (Jacobson and Gao, 2006; Spedding and William, 1996; Williams, 1999; Williams and Jarvis, 2000).”
New potent, short-linker BODIPY-630/650™ labelled fluorescent adenosine receptor agonists
Dale, C. L., Hill, S. J., & Kellam, B. (2011) · MedChemComm · doi:10.1039/c2md00247g · Cited by 31
Glutamine, Glucose and other Fuels for Cancer
Ruiz-Pérez, M. V., Sánchez‐Jiménez, F., Alonso, F. J., Segura, J., Márquez, J., & Medina, M. Á. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990482 · Cited by 35
Pathways and Mechanism of Caffeine Binding to Human Adenosine A2A Receptor
Do, H. N., Akhter, S., & Miao, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.673170 · Cited by 31
Current therapeutic targets and multifaceted physiological impacts of caffeine
Song, X., Kirtipal, N., Lee, S., Malý, P., & Bharadwaj, S. (2023) · Phytotherapy Research · doi:10.1002/ptr.8000 · Cited by 36
“ARs (i.e., A 1 AR, A 2A AR, A 2B AR, and A 3 AR) are characterized as a group of glycoproteins with seven transmembrane domains that belong to Class A G-protein-coupled receptors (Fredholm et al., 1997; Jacobson & Gao, 2006).”
BackgroundLauro, C., Catalano, M., Paolo, E. D., Chece, G., de Costanzo, I., Trettel, F., & Limatola, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00472 · Cited by 35
“Adenosine is a metabolite that acts through different receptor subtypes (Jacobson and Gao, 2006); among them A1R (Lauro et al.”
BackgroundAurelio, L., Valant, C., Flynn, B. L., Sexton, P. M., White, J. M., Christopoulos, A., & Scammells, P. J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1008538 · Cited by 31
Mayer, P., Hinze, A. V., Harst, A., & von Kügelgen, I. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq371 · Cited by 33
Scarfı̀, S. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i2.153 · Cited by 31
Neoceptors: reengineering GPCRs to recognize tailored ligands
Jacobson, K. A., Gao, Z., & Liang, B. T. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.01.006 · Cited by 31
“Since the ratio of selective enhancement of MRS1960 was only modest, we improved the interaction based on prediction from molecular modeling [4,25].”
MethodSelf-citationDolzhenko, A. V., Pastorin, G., Dolzhenko, A. V., & Chui, W. K. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.10.003 · Cited by 31
Romagnoli, R., Baraldi, P. G., IJzerman, A. P., Massink, A., Cruz‐López, O., Lopez-Cara, L. C., Saponaro, G., Preti, D., Tabrizi, M. A., Baraldi, S., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008853 · Cited by 31
Arsyad, A., & Dobson, G. P. (2016) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-016-0067-8 · Cited by 31
“Adenosine exerts it cellular effects by binding to four major subtypes of the G-protein-coupled receptors; A1, A2a, A2b, and A3 which activate intracellular survival kinase pathways in a cell- and tissue-specific manner [2, 3, 5, 6].”
BackgroundMichielan, L., Bacilieri, M., Schiesaro, A., Bolcato, C., Pastorin, G., Spalluto, G., Cacciari, B., Klotz, K., Kaseda, C., & Moro, S. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700300w · Cited by 31
Romagnoli, R., Baraldi, P. G., Carriòn, M. D., Lopez-Cara, L. C., Cruz‐López, O., Salvador, M. K., Preti, D., Tabrizi, M. A., Moorman, A. R., Vincenzi, F., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3007504 · Cited by 31
Adenosine A1 Receptors Link to Smooth Muscle Contraction Via CYP4a, protein kinase C-α, and ERK1/2
Kunduri, S. S., Mustafa, S. J., Ponnoth, D. S., Dick, G. M., & Nayeem, M. A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182919591 · Cited by 30
“Candidates for PLCX include PLCb1, PLCb3, and PLCg1, whereas candidates for GX include Gi, Go, Gq, G11, and G-bg subunits.(3,17) PLCX produces 2 second messengers from phos-”
BackgroundKaur, T., Weadick, B., Mace, T. A., Desai, K., Odom, H., & Govindarajan, R. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108300 · Cited by 36
Shu, J., Zhang, F., Zhang, L., & Wei, W. (2016) · Inflammation Research · doi:10.1007/s00011-016-1011-5 · Cited by 31
“cAMP regulates gene expression via PKA and CREB protein [56, 57].”
BackgroundKutryb-Zając, B. A., Harasim, G., Jędrzejewska, A., Król, O., Braczko, A., Jabłońska, P., Mierzejewska, P., Zieliński, J., Slominska, E. M., & Smolenski, R. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073764 · Cited by 30
“[21] It is believed that AR activation on immune cells regulates inflammatory functions and switches immune surveillance and host defense to promotion of cancer transformation and growth.”
Adenosine Signaling in Mast Cells and Allergic Diseases
Garcia-Garcia, L., Ollé, L., Martín, M., Roca‐Ferrer, J., & Muñoz‐Cano, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105203 · Cited by 30
“High levels of Ca2+ stimulate protein kinase C (PKC) and other calcium-binding proteins [37].”
BackgroundGaudin, A., Lepêtre‐Mouelhi, S., Mougin, J., Parrod, M., Pieters, G., Garcia‐Argote, S., Loreau, O., Goncalves, J., Chacun, H., Courbebaisse, Y., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.016 · Cited by 36
“Moreover selective agonists/antagonists of adenosine receptors or adenosine itself have been engaged in clinical trials for numerous applications [2] as diverse asperioperativecardioprotection[44],asthma[45],arthritis[46]ordiabe-tes [47] treatments.”
Kecskés, A., Tosh, D. K., Wei, Q., Gao, Z., & Jacobson, K. A. (2011) · Bioconjugate Chemistry · doi:10.1021/bc1005812 · Cited by 30
Self-citationKim, H., Kang, J. W., Lee, S., Choi, W. J., Jeong, L. S., Yang, Y. D., Hong, J. T., & Yoon, D. Y. (2010) · PubMed · Cited by 30
Xia, L., Burger, W. A. C., van Veldhoven, J. P. D., Kuiper, B. J., van Duijl, T. T., Lenselink, E. B., Paasman, E., Heitman, L. H., & IJzerman, A. P. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00950 · Cited by 30
“…human adenosine A 3 receptor ligands were screened in a so-called “ dual-point ” competition association Compounds with a KRI value less than 0.7 or greater than 1.5 were selected for complete kinetic characterization through the use of a competition association assay with [ 3 H] 34 (Figure 1A).”
InfluentialGrandoch, M., Hoffmann, J., Roeck, K., Wenzel, F., Oberhuber, A., Schelzig, H., & Fischer, J. W. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0340-6 · Cited by 29
“Adenosine signals in an autocrine and paracrine manner via four known receptor subtypes: A1R, A2AR, A2BR, and A3R [25].”
BackgroundAdenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy
Kalhan, A., Gharibi, B., Vazquez, M., Jasani, B., Neal, J., Kidd, M. S., Modlin, I. M., Pfragner, R., Rees, A., & Ham, J. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9280-5 · Cited by 30
“For example adenosine has been shown to modulate the migration of colon cancer cells via an HIF1α/VEGF/IL (interleukin)-8-dependent mechanism [14, 20] and A3R agonism inhibits proliferation or stimulates apoptosis in breast cancer and colon carcinoma cells [21– 23].”
BackgroundAdenosine Receptor PET Imaging in Human Brain
Mishina, M., & Ishiwata, K. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00002-7 · Cited by 29
Purinergic signaling during Porphyromonas gingivalis infection
Almeida-da-Silva, C. L. C., Morandini, A. C., Ulrich, H., Ojcius, D. M., & Coutinho‐Silva, R. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.08.003 · Cited by 32
“The receptors A1 and A3 are coupled to protein Gi, and A2A and A2B becoming associated with protein Gs [37,38].”
BackgroundMolecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends
Al‐Shar’i, N. A., & Al-Balas, Q. A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190304123414 · Cited by 30
Latasa, M. U., Gil, C., Fernández‐Barrena, M. G., Rodríguez‐Ortigosa, C. M., Bañales, J. M., Urtasun, R., Goñi, S., Méndez, M., Arcelus, S., Juanarena, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015690 · Cited by 30
“MTA is structurally very close to adenosine, a potent endogenous immune regulatory molecule produced mainly by cells of the immune system during tissue injury and inflammation [33].”
BackgroundThe Antiepileptic Potential of Nucleosides
Kovács, Z., Kékesi, K. A., Juhász, G. D., & Dobolyi, Á. (2014) · Current Medicinal Chemistry · doi:10.2174/1381612819666131119154505 · Cited by 30
“The modulatory role of Ado in different brain diseases involving epilepsy has been investigated extensively [31, 32, 85-87], and some of the drugs that have effects on the adenosinergic system (e.”
BackgroundKretschmar, C., Oyarzun, C. E., Villablanca, C., Jaramillo, C., Alarcón, S., Perez, G., Encarnación, M. M. D., Pastor‐Anglada, M., Garrido, W., Quezada, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147430 · Cited by 33
“the anti-inflammatory effect of A3AR agonists has been previously suggested [43,44].”
BackgroundYu, J., Zhao, L., Park, J., Lee, H. W., Sahu, P. K., Cui, M., Moss, S. M., Hammes, E., Warnick, E., Gao, Z.-G., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00241 · Cited by 29
Self-citationPhosri, S., Bunrukchai, K., Parichatikanond, W., Sato, V. H., & Mangmool, S. (2018) · Purinergic Signalling · doi:10.1007/s11302-017-9600-5 · Cited by 30
Potential role of adenosine A2A receptors in the treatment of schizophrenia
Wardas, J. (2008) · Frontiers in bioscience · doi:10.2741/2995 · Cited by 35
“Moreover, an action of CGS21680 compounds also on the A1 receptors cannot be fully excluded, since the affinity of this compound for A2A receptors is about 10 times higher than to A1 receptor (193).”
BackgroundMethotrexate attenuates vascular inflammation through an adenosine-microRNA-dependent pathway
Yang, D., Haemmig, S., Zhou, H., Pérez‐Cremades, D., Sun, X., Chen, L., Li, J., Haneo-Mejia, J., Yang, T., Hollan, I., et al. (2021) · eLife · doi:10.7554/elife.58064 · Cited by 29
Allosteric Modulation of Adenosine A2A Receptors as a New Therapeutic Avenue
Korkutata, M., Agrawal, L., & Lazarus, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042101 · Cited by 31
“Early studies demonstrated that amiloride and its analogs are allosteric A2AR inhibitors [17,18,69].”
BackgroundThe potential therapeutic role of extracellular vesicles in osteoarthritis
Zhuang, Y., Jiang, S., Yuan, C., & Lin, K. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1022368 · Cited by 34
The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Szentmiklosi, A. J., Galajda, Z., Cseppentö, A., Gesztelyi, R., Susán, Z., Hegyi, B., & Nánási, P. P. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141029100346 · Cited by 28
“AMISTAD I, AMISTAD II, ADVICE, ADELINE, PROTECT, TEMPEST, ADVANCE MPI1, ADVANCE MPI2, THE REOPENAMI STUDY, ADVISE II, RABIT1D) [19-21].”
BackgroundTeramachi, J., Kukita, A., Li, Y.-J., Ushijima, Y., Ohkuma, H., Wada, N., Watanabe, T., Nakamura, S., & Kukita, T. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.9 · Cited by 29
“Adenosine is a key endogenous molecule, which regulates tissue function by activating G-protein-coupled adenosine receptors (ARs)”
BackgroundPal, S., Choi, W. J., Choe, S. A., Heller, C. L., Gao, Z., Chinn, M., Jacobson, K. A., Hou, X., Lee, S. K., Kim, H. O., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.03.034 · Cited by 28
Self-citationCosentino, S., Banfi, C., Burbiel, J. C., Luo, H., Tremoli, E., & Abbracchio, M. P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01382.x · Cited by 30
“However in our experimental model, ATPinduced cytotoxicity was not counteracted by either 8- cyclopentyl-1,3-dipropylxanthine (CPX, which primarily antagonizes the A1 and A2B receptors [52–54]), or by the selective A2A antagonist SCH58261, or by the selective A3 antagonist MRS1220 [51] (data not shown), thus ruling ou…”
BackgroundMethodInfluentialTebano, M. T., Martire, A., & Popoli, P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.051 · Cited by 34
Nakata, H., Suzuki, T., Namba, K., & Oyanagi, K. (2010) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2010.509729 · Cited by 28
“Because P1 and P2 receptors are involved in a wide range of diseases, including cardiovascular, neurological, urogenital, and respiratory conditions, purinergic compounds have been exploited in drug development (72,73).”
BackgroundAdenosine receptors in rat and human pancreatic ducts stimulate chloride transport
Novak, I., Hede, S. E., & Hansen, M. R. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0403-3 · Cited by 28
“Apart from acting as a secretory agonist, extracellular adenosine can, in many tissues, act as a local modulator, which has general cytoprotective function [ 17 ].”
BackgroundInfluentialKumar, T. S., Mishra, S., Deflorian, F., Yoo, L. S., Phan, K., Kecskés, M., Szabó, A. E., Shinkre, B. A., Gao, Z., Trenkle, W. C., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.082 · Cited by 28
Self-citationStefanachi, A., Nicolotti, O., Leonetti, F., Cellamare, S., Campagna, F., Loza, M. I., Brea, J. M., Mazza, F., GAVUZZO, E., & Carotti, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.067 · Cited by 28
Initial Evaluation of an Adenosine A2AReceptor Ligand,11C-Preladenant, in Healthy Human Subjects
Sakata, M., Ishibashi, K., Imai, M., Wagatsuma, K., Ishii, K., Zhou, X., de Vries, E. F. J., Elsinga, P. H., Ishiwata, K., & Toyohara, J. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.188474 · Cited by 28
Prevention and Treatment of Sleep Deprivation Among Emergency Physicians
Nelson, D. S. (2007) · Pediatric Emergency Care · doi:10.1097/01.pec.0000280519.30570.fa · Cited by 31
“Caffeine use results in increased alertness, less fatigue, and decreased reaction time.(29) These beneficial effects occur in sleep-deprived subjects, particularly at the circadian performance nadir.”
BackgroundAdenosine 2A receptors in acute kidney injury
Vincent, I. S., & Okusa, M. D. (2015) · Acta Physiologica · doi:10.1111/apha.12508 · Cited by 27
“The A1R and A3R subtypes inhibit adenylate cyclase and activate phospholipase C (Jacobson & Gao 2006).”
BackgroundThe Role of Adenosine Signaling in Sickle Cell Therapeutics
Field, J. J., Nathan, D. G., & Linden, J. M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.003 · Cited by 27
Nayak, A., Chandra, G., Hwang, I., Kim, K., Hou, X., Kim, H. O., Sahu, P. K., Roy, K. K., Yoo, J., Lee, Y., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4015313 · Cited by 27
Self-citationDiscovery of A New Human A2AAdenosine Receptor Agonist, Truncated 2-Hexynyl-4′-thioadenosine
Hou, X., Kim, H. O., Alexander, V. M., Kim, K., Choi, S., Park, S.-G., Lee, J. H., Yoo, L. S., Gao, Z.-G., Jacobson, K. A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1001823 · Cited by 27
Self-citationHuang, X., Mao, W., Zhang, T., Wang, M., Wang, X., Li, Y., Zhang, L., Yao, D., Cai, X., & Wang, L. (2018) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-018-2364-9 · Cited by 27
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Zhang, L., Sun, H., Zhao, J., Lee, J., Low, L. E., Gong, L., Chen, Y., Wang, N., Zhu, C., Lin, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113832 · Cited by 28
The immunomodulatory function of adenosine in sepsis
Zhang, T., Yu-Jing, L., & Ma, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936547 · Cited by 34
“variety of kinase pathways, such as mitogen-activated protein (MAP) kinase, protein kinase C and phosphoinositide 3 (PI3) kinase (32).”
BackgroundSong, N., Dong, R., Pu, Y., Wang, E., Xu, J., & Guo, F. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00767-z · Cited by 28
“Figure 4c displays the confusion matrix of PMF-CPI on the test set, annotating the number of true positives 280, true negatives 754, false positives 34, and false negatives 39.”
BackgroundFunctional and RNA Expression Profile of Adenosine Receptor Subtypes in Mouse Mesenteric Arteries
Teng, B., Fil, D., Tilley, S. L., Ledent, C. A., Krahn, T., & Mustafa, S. J. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318278575e · Cited by 27
“It is well established that A2A and A2B AR mediate vasodilation, whereas A1 and A3 AR mediate vasoconstriction in adenosine-induced vascular reactivity in most vascular tissues.(5,16,17) Using genetic KO mice and specific agonists, our study provides direct evidence that A2B AR predominantly mediates adenosine-induced…”
BackgroundKim, S. Y., Seo, M.-R., Kim, Y., Lee, Y.-I., Oh, J., Cho, E.-A., Kang, J., & Juhnn, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702344200 · Cited by 27
Szopa, A., Poleszak, E., Bogatko, K., Wyska, E., Wośko, S., Doboszewska, U., Świąder, K., Właź, A., Dudka, J., Wróbel, A., et al. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1551-z · Cited by 27
Hirata, Y., Kakiuchi, M., Robson, S. C., & Fujisaki, J. (2018) · Haematologica · doi:10.3324/haematol.2018.198283 · Cited by 29
“CD39 is known to convert extracellular adenosine triphosphate (ATP) and adenosine diphosphate (ADP) into adenosine monophosphate (AMP) which is further hydrolyzed by the other cell-surface ectoenzyme, CD73, into extracellular adenosine, a purine nucleotide with various tissue-protective effects.(8) The results of our…”
A2B Adenosine Receptor Antagonists with Picomolar Potency
Jiang, J., Seel, C. J., Temirak, A., Namasivayam, V., Arridu, A., Schabikowski, J., Baqi, Y., Hinz, S., Hockemeyer, J., & Müller, C. E. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00071 · Cited by 28
Kiesewetter, D. O., Lang, L., Ma, Y., Bhattacharjee, A. K., Gao, Z., Joshi, B. V., Melman, A., de Castro, S., & Jacobson, K. A. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.10.003 · Cited by 27
“[1] Briefly, as shown in Figures 1A and 1B, MRS1220 (N-[9-chloro-2-(2-furanyl)[1,2,4]triazolo[1,5-c] quinazolin-5-yl]benzeneacetamide), a selective antagonist for the human A3AR was shown to be ineffective at rat A3AR.”
BackgroundMethodSelf-citationVarano, F., Catarzi, D., Squarcialupi, L., Betti, M., Vincenzi, F., Ravani, A., Varani, K., Ben, D. D., Thomas, A., Volpini, R., et al. (2015) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2015.04.010 · Cited by 25
Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis
Rizvi, Y. Q., Mehta, C. S., & Oyekan, A. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.09.001 · Cited by 26
“Agonists of adenosine receptor have proven effective in the treatment of many cardiovascular disorders including, arrhythmia and cardiac ischemia (Jacobson and Gao, 2006).”
BackgroundAdenosine Receptors as Novel Targets for the Treatment of Various Cancers
Gorain, B., Choudhury, H., Yee, G. S., & Bhattamisra, S. K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716102037 · Cited by 30
Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
Baudel, M. A. S. M., Espinosa‐Tanguma, R., Nieves‐Cintrón, M., & Navedo, M. F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00329 · Cited by 29
“P1 receptors A2A and A2B are coupled to AC through the activation of Gs proteins where they mediate relaxation, whereas A1 and A3 are coupled to Gi proteins and mediate vasoconstriction (124).”
BackgroundKey Elements of Gingival Epithelial Homeostasis upon Bacterial Interaction
Lee, J. S., & Yilmaz, Ö. (2020) · Journal of Dental Research · doi:10.1177/0022034520973012 · Cited by 30
“The A2a receptor is sensitive to extracellular adenosine and suppresses inflammation through cAMP-dependent activation of Akt, CREB, and NF-kB (Jacobson and Gao 2006).”
BackgroundCaffeine Inhibits Direct and Indirect Angiogenesis in Zebrafish Embryos
Basnet, R. M., Zizioli, D., Muscò, A., Finazzi, D., Sigala, S., Rossini, E., Tobia, C., Guerra, J., Presta, M., & Memo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094856 · Cited by 28
“Caffeine acts primarily by adenosine receptor antagonism and phosphodiesterase inhibition [14,15].”
BackgroundTherapeutic approaches for tumor necrosis factor inhibition
Barbosa, M. L. D. C., Fumian, M. M., Miranda, A. L. P., Barreiro, E. J., & Lima, L. M. (2011) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502011000300002 · Cited by 30
Roseti, C., Palma, E., Martinello, K., Fucile, S., Morace, R., Esposito, V., Cantore, G. P., Arcella, A., Giangaspero, F., Aronica, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907324106 · Cited by 26
“These results may help identify new treatments targeted at increasing the inhibitory GABAA efficacy, possibly leading to the development of a new family of adjuvant antiepileptic drugs to add to the large list of adenosine-related compounds currently available (12).”
BackgroundA selective adenosine sensor derived from a triplex DNA aptamer
Patel, M. R., Dutta, A., & Huang, H. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-4996-1 · Cited by 26
Substructure‐Based Virtual Screening for Adenosine A 2A Receptor Ligands
van der Horst, E., van der Pijl, R., Mulder‐Krieger, T., Bender, A., & IJzerman, A. P. (2011) · ChemMedChem · doi:10.1002/cmdc.201100369 · Cited by 26
In silico directed chemical probing of the adenosine receptor family
Areias, F. M., Brea, J. M., Gregori‐Puigjané, E., Zaki, M. E. A., Carvalho, M. A., Domínguez, E., Gutiérrez‐de‐Terán, H., Proença, M. F. R. P., Loza, M. I., & Mestres, J. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.048 · Cited by 26
Metadata
- Authors
- Jacobson, K. A., & Gao, Z.-G.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Jacobson, Kenneth A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-03
- Volume
- 5
- Issue
- 3
- Pages
- 247-264
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3463109
- OpenAlex
- W1985598247
- Cited by
- 1,431
- References
- 215
- Citations by year
- 2026: 34 · 2025: 50 · 2024: 52 · 2023: 55 · 2022: 80 · 2021: 58 · 2020: 65 · 2019: 79 · 2018: 66 · 2017: 59 · 2016: 65 · 2015: 64 · 2014: 80 · 2013: 80 · 2012: 83
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK031117)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- adenosine receptors, adenosine receptor agonists, adenosine receptor antagonists, selective ligands, caffeine, cardiovascular disease, ischemic diseases, sleep disorders, inflammatory diseases, cancer, neurological disorders, drug development
- MeSH terms
- Animals, Disease, Drug Therapy, Humans, Ligands, Structure-Activity Relationship, Molecular Structure, Signal Transduction, Receptors, Purinergic P1, Purinergic P1 Receptor Agonists, Purinergic P1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.